COVID-19 vaccine: Italy first EU country to produce Sputnik V
Sputnik V has not yet been approved for use in the EU, but the body s regulator, the European Medicines Agency, started a rolling review of the vaccine last week
Associated Press | March 10, 2021 | Updated 09:04 IST
Russian authorities are working on 20 similar collaborations in Europe and the Sputnik V vaccine has been registered in 45 nations worldwide
Russia has signed a deal to produce its Sputnik V coronavirus vaccine in Italy, the first contract in the European Union, the Italian Russian Chamber of Commerce announced Tuesday. The deal was signed with Adienne Srl, the Italian subsidiary of a Swiss-based pharmaceutical company, and Kirill Dmitriev, CEO of the Russian Direct Investment Fund. Production of a planned 10 million doses this year is set to launch in July.